FIRST QUARTER RESULTS Cash Position: As of March 31, 2025, Cingulate had approximately $9.5 million in cash and cash equivalents, a $2.7 million decrease from December 31, 2024 and cash runway into ...

NDA Submission On-Target for Mid-2025KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed ...

& Kaang, B. K. (2025). Processing of pain and itch information by modality-specific neurons within the anterior cingulate cortex in mice. Nature Communications, 16 (1), 2137.

Learn more about services at Mayo Clinic.About this study The purpose of this study is to evaluate the effectiveness and safety of bilateral stimulation of the SCCwm using the Infinity DBS system as ...

The subjects in the study were given a single 50mg dose of CTx-1301, Cingulate’s highest dosage, to determine if the medication can be taken in fed and fasted states. No serious adverse events ...

This area is often the subcallosal cingulate gyrus or the nucleus accumbens, though other targets are also used. Device function: The electrode is connected to a device implanted under the skin ...

The subcallosal cingulate gyrus in the context of major depression. Biol Psychiatry 2011; 69: 301–308. PubMed Google Scholar Etievant A, Lucas G, Dkhissi-Benyahya O, Haddjeri N .

Cingulate Inc. (NASDAQ: CING) shares are on an upward trajectory Friday. It follows the announcement that Cingulate has been granted European Patent No. 3261625 for its flagship asset, CTx-1301 ...

This study confirmed the safety and feasibility of subcallosal cingulate DBS as a treatment for treatment-resistant depression but did not show statistically significant antidepressant efficacy in a 6 ...

Over 2.5 times as many males experience anterior shoulder dislocation as females. It is most common from 15 to 30 years of age. People who play sports have a high rate of further anterior shoulder ...

The anterior cingulate plays a significant role in empathy and regulates emotional response. The researchers analyzed brain imaging tests of 85 regular cannabis consumers and 51 controls (or non-users ...